Institut Du Cancer De Montpellier - Val D'aurelle

This study is testing whether adding the chemotherapy drug irinotecan to the targeted drug regorafenib works better than regorafenib alone for people with advanced colorectal cancer that has spread and stopped responding to all standard treatments. It involves 377 participants wh…

This large study is testing whether adding an extra, focused dose of radiation to the tumor site helps prevent cancer from returning in women with a very early form of breast cancer called DCIS. All participants had surgery to remove the cancer followed by standard whole-breast r…

This study is testing whether a newer, more precise radiation tracking system causes fewer long-term side effects in the pelvic area compared to standard radiation for prostate cancer. Men with low- or intermediate-risk prostate cancer will be randomly assigned to receive radiati…

This study is testing whether adding a new pressurized aerosol chemotherapy (PIPAC) directly into the abdomen, along with standard intravenous chemotherapy, works better than standard IV chemo alone for people with advanced peritoneal mesothelioma who cannot have surgery. The mai…

This study aims to validate a new molecular test to better determine if thyroid nodules are cancerous. It involves 71 patients with inconclusive biopsy results. The goal is to improve diagnosis so fewer people undergo surgery for benign nodules.

This study is testing whether a special program combining physiotherapy, yoga, and patient education can help reduce stress, pain, and fatigue in women undergoing brachytherapy for cervical cancer. 98 women are being randomly assigned to receive either this program or standard ca…